Governor Abbott, DSHS Announce Distribution Of COVID-19 Antibody Therapy to Hospitals Across Texas

Texas Health and Human Services Commission sent this bulletin at 11/13/2020 05:22 PM CST / Este e-mail ha sido enviado por Texas Health and Human Services Commission el 11/13/2020 05:22 PM CST
NEW LOGO - SMALLER
Blue Gradient

Governor Abbott, DSHS Announce Distribution Of COVID-19 Antibody Therapy to Hospitals Across Texas

Governor Greg Abbott announced on Nov. 13 that the Texas Department of State Health Services is allocating an initial shipment of bamlanivimab, the monoclonal antibody therapy, to be distributed as early as Nov.16 to acute care hospitals across the state. These weekly shipments of doses have been provided to the state at no cost through the U.S. Department of Health and Human Services.

DSHS will allocate this initial distribution of bamlanivimab based on three criteria: 

  • new confirmed cases of COVID-19 in the community;
  • new lab-confirmed COVID-19 admissions to hospitals; and
  • total lab-confirmed COVID-19 patients in hospitals.

Bamlanivimab is for outpatient use in people who have tested positive for COVID-19 and are at increased risk of severe disease. It has been shown to prevent hospitalizations in some patients when used before they become very sick.

Read the full press release.